NCT06949020View on ClinicalTrials.gov

A Dose-finding Study of JMKX003142 in Treatment of Cardiac Edema

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

May 31, 2027

Conditions
Cardiac Edema
Interventions
DRUG

JMKX003142 Injection

JMKX003142 injection for experimental groups once daily for five days.

DRUG

JMKX003142 Injection

JMKX003142 injection for experimental groups once daily for five days.

DRUG

JMKX003142 Injection

JMKX003142 injection for experimental groups once daily for five days.

DRUG

JMKX003142 placebo

JMKX003142 placebo for placebo groups once daily for five days.

Sponsors

Lead Sponsor

Jemincare
All Listed Sponsors
lead

Jemincare

INDUSTRY

NCT06949020 - A Dose-finding Study of JMKX003142 in Treatment of Cardiac Edema | Biotech Hunter | Biotech Hunter